2051 - 2100 of 9145 Results
Title
Year
- Parkinson's Kinesia Paradoxa Is Not a Paradox2021OPENTitle: Parkinson's Kinesia Paradoxa Is Not a ParadoxJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1115End Page: 1118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28550Citation Count: 34
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 25
- Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSA2021RESTRICTEDTitle: Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1466End Page: 1467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28571Citation Count: 6
- Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”2021RESTRICTEDTitle: Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28588Citation Count: 0
-
OPENTitle: Movement Disorders and SARS‐CoV‐2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page: S9End Page: S17Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13615Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10448146/pdf/MDC3-10-S9.pdfCitation Count: 4
-
OPENTitle: Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page: S56End Page: S62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13616Best OA location URL: https://doi.org/10.1002/mdc3.13616Citation Count: 12
- A conversation with Judith Campisi: Leader in the field of aging research2021OPENTitle: A conversation with Judith Campisi: Leader in the field of aging researchJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 69Issue #:Start Page: 101366End Page: 101366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2021.101366Citation Count: 2
-
OPENTitle: Data imputation and compression for Parkinson's disease clinical questionnairesJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 114Issue #:Start Page: 102051End Page: 102051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051Best OA location URL: https://hal.science/hal-02570967/documentCitation Count: 30
- In-Home Falls Risk Assessment in Parkinson Disease: A Guide for Clinicians2021OPENTitle: In-Home Falls Risk Assessment in Parkinson Disease: A Guide for CliniciansJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 102Issue #: 10Start Page: 2051End Page: 2054Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2021.04.001Citation Count: 3
- Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing2021RESTRICTEDTitle: Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursingJournal Name: Archives of Psychiatric NursingPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 284End Page: 289Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.apnu.2021.03.006Citation Count: 8
- A high dose tango intervention for people with Parkinson's disease (PwPD)2021RESTRICTEDTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Citation Count: 6
- Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetJournal Name: Pharmacological ReportsPublisher: Springer Science and Business Media LLCVol: 74Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43440-022-00378-9Citation Count: 5
- Role of Neuroinflammation in the Establishment of the Neurogenic Microenvironment in Brain Diseases2021RESTRICTEDTitle: Role of Neuroinflammation in the Establishment of the Neurogenic Microenvironment in Brain DiseasesJournal Name: Current Tissue Microenvironment ReportsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 2Start Page: 17End Page: 28Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43152-021-00028-xCitation Count: 3
- Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation2021RESTRICTEDTitle: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on NeuroinflammationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 59Issue #: 2Start Page: 1140End Page: 1150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1Citation Count: 19
- Mathematical model for early stage identification of Parkinson’s disease using neurotransmitter: GABA2021RESTRICTEDTitle: Mathematical model for early stage identification of Parkinson’s disease using neurotransmitter: GABAJournal Name: International Journal of Information TechnologyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 265End Page: 273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s41870-021-00705-yCitation Count: 11
- No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects2021RESTRICTEDTitle: No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjectsJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1187End Page: 1192Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01657-wCitation Count: 1
- Frühzeichen der Parkinson-Erkrankung2021RESTRICTEDTitle: Frühzeichen der Parkinson-ErkrankungJournal Name: DGNeurologiePublisher: Springer Science and Business Media LLCVol: 4Issue #: 4Start Page: 295End Page: 303Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s42451-021-00352-4Citation Count: 0
- Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT images2021RESTRICTEDTitle: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT imagesJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1203End Page: 1213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01661-0Citation Count: 18
- Does Head Tremor Predict Postural Instability After Bilateral Thalamic Stimulation in Essential Tremor?2022RESTRICTEDTitle: Does Head Tremor Predict Postural Instability After Bilateral Thalamic Stimulation in Essential Tremor?Journal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 1039End Page: 1044Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-022-01477-2Citation Count: 3
- Slowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies2022RESTRICTEDTitle: Slowing Parkinson’s Disease Progression with Vaccination and Other ImmunotherapiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 4Start Page: 327End Page: 343Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00903-7Citation Count: 8
-
OPENTitle: Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making ImportantJournal Name: NeuroethicsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12152-022-09496-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12152-022-09496-w.pdfCitation Count: 4
- Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation System2022RESTRICTEDTitle: Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation SystemJournal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 47Issue #: 10Start Page: 3192End Page: 3201Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11064-022-03673-2Citation Count: 5
- Quality of life after hospitalization predicts one-year readmission risk in a large Swiss cohort of medical in-patients2021RESTRICTEDTitle: Quality of life after hospitalization predicts one-year readmission risk in a large Swiss cohort of medical in-patientsJournal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 7Start Page: 1863End Page: 1871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11136-021-02867-5Citation Count: 3
- Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRI2022RESTRICTEDTitle: Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRIJournal Name: NeuroinformaticsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 4Start Page: 879End Page: 896Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12021-022-09565-8Citation Count: 5
- Association of Total Bilirubin with Motor Signs in Early Parkinson’s Disease in LRRK2 Variant Carriers2022RESTRICTEDTitle: Association of Total Bilirubin with Motor Signs in Early Parkinson’s Disease in LRRK2 Variant CarriersJournal Name: Journal of Molecular NeurosciencePublisher: Springer Science and Business Media LLCVol: 72Issue #: 11Start Page: 2338End Page: 2344Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12031-022-02067-xCitation Count: 2
- Incidence of Parkinson’s disease in French women from the E3N cohort study over 27 years of follow-up2022RESTRICTEDTitle: Incidence of Parkinson’s disease in French women from the E3N cohort study over 27 years of follow-upJournal Name: European Journal of EpidemiologyPublisher: Springer Science and Business Media LLCVol: 37Issue #: 5Start Page: 513End Page: 523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10654-022-00851-yCitation Count: 21
- Beyond tics: movement disorders in patients with Tourette syndrome2021RESTRICTEDTitle: Beyond tics: movement disorders in patients with Tourette syndromeJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 8Start Page: 1177End Page: 1183Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02386-0Citation Count: 43
-
OPENTitle: Dopamine denervation in the functional territories of the striatum: a new MR and atlas-based 123I-FP-CIT SPECT quantification methodJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 12Start Page: 1841End Page: 1852Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02434-9Best OA location URL: https://hal.sorbonne-universite.fr/hal-03668195Citation Count: 8
- Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 7Start Page: 4193End Page: 4201Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-05952-wCitation Count: 22
- Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4745End Page: 4752Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06110-yCitation Count: 8
- The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunction2022RESTRICTEDTitle: The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunctionJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4777End Page: 4784Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06081-0Citation Count: 6
-
OPENTitle: How to unblur the vasovagal evidence?Journal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 33Issue #: 1Start Page: 5End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00915-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-022-00915-9.pdfCitation Count: 1
- Wolframin is a novel regulator of tau pathology and neurodegeneration2022OPENTitle: Wolframin is a novel regulator of tau pathology and neurodegenerationJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 143Issue #: 5Start Page: 547End Page: 569Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-022-02417-4Citation Count: 42
- Acetyl-dl-leucine improves restless legs syndrome: a case report2021RESTRICTEDTitle: Acetyl-dl-leucine improves restless legs syndrome: a case reportJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 7Start Page: 2595End Page: 2596Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10625-3Citation Count: 7
- REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson’s disease: a cross-sectional and longitudinal study2022RESTRICTEDTitle: REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson’s disease: a cross-sectional and longitudinal studyJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 9Start Page: 4836End Page: 4845Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-022-11120-zCitation Count: 10
- Structural connectivity alterations in the motor network of patients with scans without evidence of dopaminergic deficit (SWEDD)2022RESTRICTEDTitle: Structural connectivity alterations in the motor network of patients with scans without evidence of dopaminergic deficit (SWEDD)Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 11Start Page: 5926End Page: 5933Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-022-11259-9Citation Count: 1
- The Isolation and Deep Sequencing of Mitochondrial DNA2021RESTRICTEDTitle: The Isolation and Deep Sequencing of Mitochondrial DNAJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 433End Page: 447Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-1270-5_27Citation Count: 8
- Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset2021RESTRICTEDTitle: Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 1Start Page: 73End Page: 81Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02287-8Citation Count: 17
- Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset2021RESTRICTEDTitle: Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmosetJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 394Issue #: 8Start Page: 1685End Page: 1692Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-021-02090-6Citation Count: 11
- Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset2021RESTRICTEDTitle: Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 394Issue #: 12Start Page: 2381End Page: 2388Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-021-02162-7Citation Count: 3
-
OPENTitle: LRRK2 G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environmentJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-026-03967-0Best OA location URL: https://doi.org/10.1186/s12974-026-03967-0Citation Count: 5
-
OPENTitle: Revised criteria for the diagnosis and staging of Alzheimer’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 8Start Page: 2121End Page: 2124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-024-02988-7Best OA location URL: https://www.nature.com/articles/s41591-024-02988-7.pdfCitation Count: 183
- Optimal Treatment of Depression and Anxiety in Parkinson's Disease2021RESTRICTEDTitle: Optimal Treatment of Depression and Anxiety in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 6Start Page: 530End Page: 540Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.02.037Citation Count: 66
- N-terminal acetylation does not alter α-synuclein's interfacial properties2021RESTRICTEDTitle: N-terminal acetylation does not alter α-synuclein's interfacial propertiesJournal Name: International Journal of Biological MacromoleculesPublisher: Elsevier BVVol: 174Issue #:Start Page: 69End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ijbiomac.2021.01.147Citation Count: 4
- Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau2021RESTRICTEDTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 2
- Organizations join forces to support early diagnosis of Lewy body dementia2021RESTRICTEDTitle: Organizations join forces to support early diagnosis of Lewy body dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 6Start Page: 1077End Page: 1078Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12386Citation Count: 0
- Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort2022RESTRICTEDTitle: Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 1Start Page: 226End Page: 243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12632Citation Count: 31
-
OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01312%22Citation Count: 17
- Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's disease2022RESTRICTEDTitle: Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.067067Citation Count: 6
-
OPENTitle: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 4Start Page: 1358End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12790Citation Count: 52